These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 37175652)
1. Immune Dysfunction in Medication-Related Osteonecrosis of the Jaw. Roato I; Mauceri R; Notaro V; Genova T; Fusco V; Mussano F Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175652 [TBL] [Abstract][Full Text] [Related]
2. [Position paper on medication-related osteonecrosis of the jaw (MRONJ)]. Svejda B; Muschitz Ch; Gruber R; Brandtner Ch; Svejda Ch; Gasser RW; Santler G; Dimai HP Wien Med Wochenschr; 2016 Feb; 166(1-2):68-74. PubMed ID: 26847441 [TBL] [Abstract][Full Text] [Related]
3. A real-world study on the prevalence and risk factors of medication related osteonecrosis of the jaw in cancer patients with bone metastases treated with Denosumab. Bracchi P; Zecca E; Brunelli C; Miceli R; Tinè G; Maniezzo M; Lo Dico S; Caputo M; Shkodra M; Caraceni AT Cancer Med; 2023 Sep; 12(17):18317-18326. PubMed ID: 37559413 [TBL] [Abstract][Full Text] [Related]
4. Denosumab-related osteonecrosis of the jaw: a report of 2 cases and review of the literature. Chehal H; Nikitakis NG; Islam MN; Goodchild JH; Mordini L; Bhattacharyya I Gen Dent; 2019; 67(1):42-46. PubMed ID: 30644830 [TBL] [Abstract][Full Text] [Related]
5. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw. Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278 [TBL] [Abstract][Full Text] [Related]
6. [Progress on medication-related osteonecrosis of the jaw]. Wang QZ; Liu JY; Pan J Hua Xi Kou Qiang Yi Xue Za Zhi; 2018 Oct; 36(5):568-572. PubMed ID: 30465354 [TBL] [Abstract][Full Text] [Related]
7. Etiopathogenesis of medication-related osteonecrosis of the jaws: a review. Bassan Marinho Maciel G; Marinho Maciel R; Linhares Ferrazzo K; Cademartori Danesi C J Mol Med (Berl); 2024 Mar; 102(3):353-364. PubMed ID: 38302741 [TBL] [Abstract][Full Text] [Related]
8. The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors. Dodson TB Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):509-16. PubMed ID: 26362367 [TBL] [Abstract][Full Text] [Related]
9. Emerging antiresorptive medications and their potential implications for dental surgeries. Aminoshariae A; Donaldson M; Horan M; Mackey SA; Kulild JC; Baur D J Am Dent Assoc; 2022 Jul; 153(7):649-658. PubMed ID: 35277242 [TBL] [Abstract][Full Text] [Related]
10. Management of Medication-Related Osteonecrosis of the Jaw. Williams WB; O'Ryan F Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):517-25. PubMed ID: 26515735 [TBL] [Abstract][Full Text] [Related]
11. Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: Is tooth extraction a risk factor? Soutome S; Hayashida S; Funahara M; Sakamoto Y; Kojima Y; Yanamoto S; Umeda M PLoS One; 2018; 13(7):e0201343. PubMed ID: 30048523 [TBL] [Abstract][Full Text] [Related]
12. One changing and challenging scenario: the treatment of cancer patients with bone metastases by bisphosphonates and denosumab, the cost-benefit evaluation of different options, and the risk of medication-related osteonecrosis of the jaw (MRONJ). Fusco V; Campisi G; Bedogni A Support Care Cancer; 2022 Sep; 30(9):7047-7051. PubMed ID: 35312858 [TBL] [Abstract][Full Text] [Related]
13. Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ). Otto S; Aljohani S; Fliefel R; Ecke S; Ristow O; Burian E; Troeltzsch M; Pautke C; Ehrenfeld M Medicina (Kaunas); 2021 May; 57(5):. PubMed ID: 34065104 [TBL] [Abstract][Full Text] [Related]
14. Microarchitecture of medication-related osteonecrosis of the jaw (MRONJ); a retrospective micro-CT and morphometric analysis. Schoenhof R; Munz A; Yuan A; ElAyouti A; Boesmueller H; Blumenstock G; Reinert S; Hoefert S J Craniomaxillofac Surg; 2021 Jun; 49(6):508-517. PubMed ID: 33707134 [TBL] [Abstract][Full Text] [Related]
15. Medication-related osteonecrosis of the jaw: A literature review and update. Kuroshima S; Al-Omari FA; Sasaki M; Sawase T Genesis; 2022 Sep; 60(8-9):e23500. PubMed ID: 36106755 [TBL] [Abstract][Full Text] [Related]
16. Treatment of Medication-Related Osteonecrosis of the Jaw: Controversies in Causality and Therapy. Halpern LR; Adams DR Dent Clin North Am; 2024 Jan; 68(1):67-85. PubMed ID: 37951638 [TBL] [Abstract][Full Text] [Related]
17. Anti-resorptive Drugs and their Impact on Maxillofacial Bone among Cancer Patients. Borumandi F; Aghaloo T; Cascarini L; Gaggl A; Fasanmade K Anticancer Agents Med Chem; 2015; 15(6):736-43. PubMed ID: 25807940 [TBL] [Abstract][Full Text] [Related]
18. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs. Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661 [TBL] [Abstract][Full Text] [Related]
19. Medication-related osteonecrosis of the jaw: An update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention. Owosho AA; Liang STY; Sax AZ; Wu K; Yom SK; Huryn JM; Estilo CL Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):440-445. PubMed ID: 29580668 [TBL] [Abstract][Full Text] [Related]
20. Antimicrobial peptide gene expression in medication-related osteonecrosis of the jaw. Thiel Y; Ghayor C; Lindhorst D; Essig H; Weber F; Rücker M; Schumann P Pathol Res Pract; 2020 Dec; 216(12):153245. PubMed ID: 33065485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]